Terms: = Breast cancer AND BCL10, CIPER, 8915, ENSG00000142867, c-E10, CARMEN, mE10, CLAP
33 results:
1. Assessment of a Genomic Assay in Patients With ERBB2-Positive breast cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab.
Bueno-Muiño C; Echavarría I; López-Tarruella S; Roche-Molina M; Del Monte-Millán M; Massarrah T; Jerez Y; Ayala de la Peña F; García-Sáenz JÁ; Moreno F; Rodríguez-Lescure Á; Malón-Giménez D; Ballesteros García AI; Marín-Aguilera M; Galván P; Brasó-Maristany F; Waks AG; Tolaney SM; Mittendorf EA; Vivancos A; Villagrasa P; Parker JS; Perou CM; Paré L; Villacampa G; Prat A; Martín M
JAMA Oncol; 2023 Jun; 9(6):841-846. PubMed ID: 37103916
[TBL] [Abstract] [Full Text] [Related]
2. UHPLC-MS/MS Studies and Antiproliferative Effects in breast cancer Cells of Mexican Sargassum.
Jonathan FM; Darling D; Cecilia RM; Alan EP; Lubriel MH; Ivonne OC; Elena MJ; Augusto RC; Sayuri VJ; Angel GL; José CB
Anticancer Agents Med Chem; 2023; 23(1):76-86. PubMed ID: 35418289
[TBL] [Abstract] [Full Text] [Related]
3. Predictors of axillary node response in node-positive patients undergoing neoadjuvant chemotherapy for breast cancer.
Ladak F; Chua N; Lesniak D; Ghosh S; Wiebe E; Yakimetz W; Rajaee N; Olson D; Peiris L
Can J Surg; 2022; 65(1):E89-E96. PubMed ID: 35135785
[TBL] [Abstract] [Full Text] [Related]
4. MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative breast cancer.
Lee JL; Ekambaram P; Carleton NM; Hu D; Klei LR; Cai Z; Myers MI; Hubel NE; Covic L; Agnihotri S; Krappmann D; Bornancin F; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
Mol Cancer Res; 2022 Mar; 20(3):373-386. PubMed ID: 34753803
[TBL] [Abstract] [Full Text] [Related]
5. Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative breast cancer Cells.
Messeha SS; Zarmouh NO; Asiri A; Soliman KFA
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33297339
[TBL] [Abstract] [Full Text] [Related]
6. Pancreatic acinar cell carcinoma with a ductal adenocarcinoma component: a case report and analysis of the histogenesis of the tumor.
Kimura T; Tabata S; Togawa T; Onchi H; Iida A; Sato Y; Goi T
World J Surg Oncol; 2020 Sep; 18(1):238. PubMed ID: 32891173
[TBL] [Abstract] [Full Text] [Related]
7. Antipsychotics drug aripiprazole as a lead against breast cancer cell line (MCF-7) in vitro.
Badran A; Tul-Wahab A; Zafar H; Mohammad N; Imad R; Ashfaq Khan M; Baydoun E; Choudhary MI
PLoS One; 2020; 15(8):e0235676. PubMed ID: 32746451
[TBL] [Abstract] [Full Text] [Related]
8. MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types.
McAuley JR; Bailey KM; Ekambaram P; Klei LR; Kang H; Hu D; Freeman TJ; Concel VJ; Hubel NE; Lee JL; Klei HB; Cheng J; Sekar P; Bridwell RE; Covic L; Lucas PC; McAllister-Lucas LM
Oncogene; 2019 Dec; 38(49):7384-7398. PubMed ID: 31420608
[TBL] [Abstract] [Full Text] [Related]
9. A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α-XBP1 Activation.
Yang Z; Zhang J; Jiang D; Khatri P; Solow-Cordero DE; Toesca DAS; Koumenis C; Denko NC; Giaccia AJ; Le QT; Koong AC
Mol Cancer Res; 2018 May; 16(5):745-753. PubMed ID: 29440447
[TBL] [Abstract] [Full Text] [Related]
10. The CARMA3-bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive breast cancer.
Ekambaram P; Lee JL; Hubel NE; Hu D; Yerneni S; Campbell PG; Pollock N; Klei LR; Concel VJ; Delekta PC; Chinnaiyan AM; Tomlins SA; Rhodes DR; Priedigkeit N; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
Cancer Res; 2018 Mar; 78(5):1225-1240. PubMed ID: 29259013
[TBL] [Abstract] [Full Text] [Related]
11. bcl10 synergistically links CEACAM3 and TLR-dependent inflammatory signalling.
Sintsova A; Guo CX; Sarantis H; Mak TW; Glogauer M; Gray-Owen SD
Cell Microbiol; 2018 Jan; 20(1):. PubMed ID: 28886618
[TBL] [Abstract] [Full Text] [Related]
12. The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy.
Pan D; Zhu Y; Zhou Z; Wang T; You H; Jiang C; Lin X
Mol Cancer Res; 2016 Jan; 14(1):93-102. PubMed ID: 26392569
[TBL] [Abstract] [Full Text] [Related]
13. Accuracy and clinical usefulness of scoliosis measurement with magnetic spine mapping--Ortelius.
Zabka M; Rehak L; Uhrin T
Bratisl Lek Listy; 2015; 116(8):469-74. PubMed ID: 26350085
[TBL] [Abstract] [Full Text] [Related]
14. Increased oxidative damage to membrane lipids following surgery for breast cancer.
Szychta P; Zadrozny M; Lewinski A; Karbownik-Lewinska M
Neuro Endocrinol Lett; 2014; 35(7):602-7. PubMed ID: 25617883
[TBL] [Abstract] [Full Text] [Related]
15. MCTP system model based on linear programming optimization of apertures obtained from sequencing patient image data maps.
Ureba A; Salguero FJ; Barbeiro AR; Jimenez-Ortega E; Baeza JA; Miras H; Linares R; Perucha M; Leal A
Med Phys; 2014 Aug; 41(8):081719. PubMed ID: 25086529
[TBL] [Abstract] [Full Text] [Related]
16. Benzene-poly-carboxylic acid complex, a novel anti-cancer agent induces apoptosis in human breast cancer cells.
Fares F; Azzam N; Fares B; Larsen S; Lindkaer-Jensen S
PLoS One; 2014; 9(2):e85156. PubMed ID: 24523856
[TBL] [Abstract] [Full Text] [Related]
17. Epithelial growth factor receptor-activated nuclear factor κB signaling and its role in epithelial growth factor receptor-associated tumors.
Pan D; Lin X
Cancer J; 2013; 19(6):461-7. PubMed ID: 24270344
[TBL] [Abstract] [Full Text] [Related]
18. New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma.
Kozanoglu I; Yandim MK; Cincin ZB; Ozdogu H; Cakmakoglu B; Baran Y
J Cancer Res Clin Oncol; 2013 Feb; 139(2):327-35. PubMed ID: 23080133
[TBL] [Abstract] [Full Text] [Related]
19. T(14;18)(q32;q21) involving MALT1 and IGH genes occurs in extranodal diffuse large B-cell lymphomas of the breast and testis.
Kuper-Hommel MJ; Schreuder MI; Gemmink AH; van Krieken JH
Mod Pathol; 2013 Mar; 26(3):421-7. PubMed ID: 23018871
[TBL] [Abstract] [Full Text] [Related]
20. breast MALT lymphomas: a clinicopathological and cytogenetic study of 9 cases.
Liguori G; Cantile M; Cerrone M; La Mantia E; Di Bonito M; Zanconati F; Curcio MP; Aquino G; La Mura A; Giannatiempo R; De Chiara A; Lombardi A; Botti G; D'Antonio A; Caraglia M; Franco R
Oncol Rep; 2012 Oct; 28(4):1211-6. PubMed ID: 22842723
[TBL] [Abstract] [Full Text] [Related]
[Next]
